MAP2K1 and breast carcinoma: Because Skp2 is located downstream in the MAPK signaling pathway, we have in the present study tested the hypothesis that Skp2 overexpression can provoke cytoplasmic localization of PPARγ upon MEK1-dependent mechanisms in human breast cancer cells.